- PDF Free Download

Sihuan Pharmaceutical Holdings Group Ltd. (a) (b) (c) (d) (e) 32 2(1 (f) (g) (h) (i) (j) (k) (l)

7.2% 7.3% 7.4% 2,000 31 10,000 14 17.1% 20 30 82.3% 78.7% 79.1% 83.0% 66.5% 60.1% 57.3% 57.7%

% % % % %... 177,505 62.0 258,822 50.8 330,864 46.7 148,203 46.0 215,899 45.6... 13,010 4.5 47,523 9.3 75,252 10.6 35,606 11.0 57,018 12.1... 29,140 10.2 49,580 9.7 63,080 8.9 29,554 9.2 41,809 8.8 (1)... 4,581 1.6 23,126 4.5 37,176 5.2 19,369 6.0 24,303 5.1... 1,775 0.4 22,837 3.2 7,877 2.4 31,277 6.6... 12,383 1.8 4,342 1.4 12,746 2.7... 11,349 4.0 20,539 4.0 19,029 2.7 9,849 3.0 9,956 2.1... 235,585 82.3 401,365 78.7 560,621 79.1 254,800 79.0 393,008 83.0... 4,233 0.8 16,130 2.3 7,226 2.2 11,521 2.4... 1,821 0.6 9,060 1.8 9,321 1.3 4,695 1.5 3,695 0.8... 2,474 0.9 8,329 1.6 7,770 1.1 3,999 1.2 3,345 0.7... 693 0.2 2,317 0.5 1,518 0.2 853 0.3 317 0.1... 12,335 4.3 22,290 4.4 20,778 2.9 10,295 3.2 11,781 2.5... 17,323 6.0 46,229 9.1 55,517 7.8 27,068 8.4 30,659 6.5 (2)... 14,727 5.2 17,270 3.4 16,143 2.3 8,211 2.6 10,436 2.2... 2,935 1.0 16,349 3.2 33,642 4.8 15,506 4.8 17,607 3.7... 245 0.1 747 0.1 2,870 0.4 1,281 0.4 1,916 0.4... 15,534 5.4 26,808 5.3 32,164 4.5 14,827 4.6 19,161 4.1... 33,441 11.7 61,174 12.0 84,819 12.0 39,825 12.4 49,120 10.4 (3)... 1,280 0.2 7,950 1.1 700 0.2 650 0.1... 286,349 100% 510,048 100% 708,907 100% 322,394 100% 473,437 100% (1) (2) Feidiao Pudiao Quxinao (3)

1319 12 % % % % % (1)... 255,436 89.2 423,123 83.0 549,875 77.6 253,017 78.5 359,110 75.9... 28,996 10.1 76,375 14.9 115,743 16.3 52,465 16.3 75,004 15.8... 1,917 0.7 10,550 2.1 43,289 6.1 16,912 5.2 39,323 8.3... 286,349 100.0% 510,048 100.0% 708,907 100.0% 322,394 100.0% 473,437 100.0 (1) 2,000 31 10,00089070% 3,600 55% 5,400 278

333 13 3010 10%

GMP GMP [2010]253 57.9% MSPEA III Cayman China Pharma

MSPEA III Cayman MSPEA Pharma BVChina Pharma 0.975 China Pharma China Pharma 76.6% MSPEA Pharma BV China Pharma (a) (b) MSPEA Pharma BV China Pharma 48,672,331.39 China Pharma China PharmaChina Pharma China Pharma China Pharma

48,672,331.39 MSPEA Pharma BV MSPEA Pharma BV MSPEA Pharma BV 48,672,331.39 47,000,000 10% Plenty Gold MSPEA Pharma BV Plenty Gold Top Matrix Top Matrix Plenty Gold 42,300,000 9% 12.766 540 NHC NHCNHC NHC NHC... 320,499 420,054 376,484 383,160... 310,047 441,997 796,958 980,195... 630,546 862,051 1,173,442 1,363,355... 10,214 18,997 29,995 10,761... 95,519 127,194 219,260 179,924... 105,733 146,191 249,255 190,685... 630,546 862,051 1,173,442 1,363,355... 214,528 314,803 577,698 800,271... 535,027 734,857 954,182 1,183,431

... 286,349 510,048 708,907 322,394 473,437... (60,526) (133,551) (191,915) (90,696) (127,074)... 225,823 376,497 516,992 231,698 346,363... 22,744 (8,014) (16,348) (29,151) 19,444... (22,732) (38,906) (48,810) (22,634) (26,364)... (38,856) (53,405) (78,809) (35,276) (52,420)... (2,527) 470 5,644 177 3,072... 10,427 2,357 2,357... 184,452 287,069 381,026 147,171 290,095... (5,626) (53,621) (67,370) (36,335) (42,683)... 178,826 233,448 313,656 110,836 247,412... 179,266 237,059 326,316 119,594 254,849... (440) (3,611) (12,660) (8,758) (7,437) 178,826 233,448 313,656 110,836 247,412... 39.93 50.44 69.43 25.45 54.22

... 182,565 256,819 385,648 171,334 183,984... (155,731) (115,365) 16,062 61,098 (2,526)... 193,758 (72,656) (120,029) (71,558) (173,939)... 41,788 262,380 331,178 331,178 612,859... 262,380 331,178 612,859 492,052 620,378 [ ] 60.7 120.0

API API

10320

China Pharma China Pharma Limited Plenty Gold China Pharma 32 MSPEA Pharma BV Plenty Gold Plenty Gold Plenty Gold CPL China Pharma

60% 20% 20% GDP Euromonitor International

IMS IMS Health Incorporated IMS IMS 60% 17% 23% 51% 34% 10% 5% API MENET

MSPEA III Morgan Stanley Private Equity Asia III, L.P. MSPEA III Cayman Morgan Stanley Private Equity Asia III Holdings (Cayman) Ltd MSPEA III Coop MSPEA III Coop MSPEA III Holdings Coöperatief U.A. MSPEA Pharma BV MSPEA III GP Morgan Stanley Private Equity Asia III, L.L.C. MSPEA III Inc. Morgan Stanley Private Equity Asia III, Inc. MSPEA Pharma MSPEA Pharma Holdings B.V. BV % Plenty Gold Plenty Gold Enterprises Limited 51% 25% 11% 10.1% 2.9%Plenty Gold

571 0.01 117

Top Matrix Top Matrix Enterprises Limited Sihuan Management (PTC) Limited Plenty Gold S

API

GMP

GSP

66.5% 60.1% 57.3% 57.7% 62.0% 50.8% 46.7% 45.6% [2010]253 23.6% 30.6% 27.7% 23.4% Harbin Tri-Lion Pharmaceutical Co., Ltd. 25.2% 34.3% 28.0%

Harbin Tri-Lion Pharmaceutical Co., Ltd. 30.4 6.8 65.0 36.4 48.2 50.8 35

600 (Spanish Committee on Drug Surveillance)

320 78.9% 73.8% 72.9% 73.2% 62.5% 45.8% 44.2% 52.3% 50.2% 50.2% API API API API 92.6 101.1 128.9 73.6 API

84.7% 68.1% 63.6% 45.3% API API API API 43.1 API API API API API API 65.1% GMP

API API

30.0% 21.6% 19.6% 16.9% API

[2007]42 [2009]387 [2010]394 79.5% 1,407.4 2.85 API 2,931.50 781.5 274,557.2 2,178 3.26 65,340 3.2

3,350.38 886,003 144.64 11,000 4.1 3.6

11,000 9,000 24,000 44,000

China Pharma 2,019,922131,600 2,019,922 131,600

93.8% 86.8% 81.5% 80.6% [2010]253 57.9%

API 3.9% 14.2%

25%

25% 25% 10% 10%

10% 25% 5% 10% 1.1

(i)(ii) (iii) 5 15

(a) (b) (c)

2.0% 1.5%3.0%

[ ] 8A 3 621 703 101 1 A-1104 18 Eddy Huang 17 10A

41A A1 8 1601 8 3 1105

Clarendon House 2 Church Street P.O. Box HM1022 Hamilton HM DX Bermuda 85 27 570105 101114 88 25 BCD 518048 2518 250101 15 8 Eddy Huang

Codan Services Company Limited Claredon House, PO Box HM 1022 Hamilton HM DX Bermuda

IMS [ ] [ ] [ ] [ ] IMS IMS[ ] IMS IMS100 IMS -IMSIMS IMS IMS 1,072 2,439 22.8% IMS 6,913 23.2%

IMS IMS 3,600 87.4%12.6% 20 24.7%2.2% IMS

IMS70% 24.0% 19.8% IMS IMS 72% IMS IMS IMS

40.4% 34.9%24.7% 60.0%

... 50.9%... 21.0%... 20.2%... 18.0%... 15.1%... 14.9%... 13.1%... 12.3%... 11.5%... 6.8% IMS 85% 20,291 892,280 5,110 6,523 1,233 IMS 48.6% 38.6% 4.3% 8.6%

% %... 16.0 81.1 146.6 4.1... 7.0 2,179.6 2,860.3 8.7... 5.4 3,036.1 3,743.9 8.8... 5.3 2,706.3 3,326.4 9.0... 5.1 3,924.9 4,789.0 10.9... 3.8 3,618.1 4,192.9 10.2... 3.2 6,598.4 7,492.5 16.3... 2.9 3,470.8 3,887.2 10.3... 2.0 2,921.5 3,166.8 8.0... 1.2 3,112.4 3,267.2 8.6 Euromonitor Euromonitor 4.1%

81.1 146.6 16.0% 10,49317,175 13.1% Economist Intelligence Unit35.8% 44.0%133.0 48.9% 77.4% 65 7.7% 100.68.5%113.165 65

90% 8,500 IMS8,500 46% 90% 40120 80120 IMS IMS 47% 5,0002,0002,400 IMS

IMS (i) (ii) (iii) (iv) (v) 68.3% IMS20% (%)... 66,081.4 27.1 175,000.0 21.5... 31,023.1 12.7 95,012.7 25.1... 28,564.4 11.7 73,823.9 20.9... 23,332.5 9.6 72,616.9 25.5... 17,381.5 7.1 50,339.4 23.7... 10,965.9 4.5 30,008.5 22.3... 5,946.1 2.4 17,015.5 23.4... 5,611.6 2.3 15,707.0 22.9... 3,229.5 1.3 9,622.5 24.4... 1,214.1 0.5 3,201.4 21.4 IMS

37 114 40% MENET 250 150 750 800 75% IMS... 1.4% 1.4% 1.8%... 0.6% 0.7% 1.0%... 1.6% 2.6% 5.5%

31,939.8 89.2% 10.8% IMS IMS 28,498.8 11,951.3 24.1%

36.4%26.9% 28.5% IMS 26.6% 7.4% (%)... 7.2 7.3 7.4... 5.6 6.1 6.2... 4.5 4.6 4.9... 3.7 4.5 4.5... 3.9 3.6 3.6 IMS

IMS (%) (%) GM1... 1,869.3 6.6 93.5... 1,528.8 5.4 54.6... 1,489.1 5.2 66.1... 1,319.5 4.6 75.8... 1,086.0 3.8 18.2 IMS (%)... 4.4 5.2 5.2... 4.0 4.3 4.4... 3.1 3.9 3.9... 3.2 3.1 2.9... 1.9 2.3 2.6 IMS

IMS 25.8% 899 IMS

500 1,300 IMS104 44 24.0% (%) (%)... 1,528.8 14.8 54.6... 1,489.1 14.4 66.1... 1,039.1 10.0 31.7... 890.1 8.6 25.5... 830.7 8.0 22.4 IMS IMS IMS

MENET 600 IMS 53 19 29.2% (%) (%) GM1... 1,869.3 35.4 93.5... 1,319.5 25.0 75.8... 733.9 13.9 10.0... 617.3 11.7 1.4... 269.0 5.1 5.5 IMS IMS IMS

IMS IMS 56 [ ] IMS IMS IMS 1 IMS IMS IMS 100 IMS

28% 20 20 60% 20 15%

MSPEA III Cayman API 60% 40% 20% 20% 20%

51% 25% 11% 13% 75% 30% 50% 20% 300,000 250,000 200,000 30% 25% 20% 75% 25% 75% 25% 750,000 250,000 9,520,000 28% 8% 5%

17% 40%2% 35.2 33.1 51% 49% 10% 90% 10%100,000 10% 10% 51% 25% 11% 13% 58,616,800

[ ] 49% 49%2,484,693.95 60 (i)(ii) (iii) 60% 40% 2,254,785.02 1,503,190.01 GSP

60% 80% 20% 800,000 20% 4,000,00050,000,000 8,500,000 37,500,000 75% 17% 8% 62,500,000 15% 60% 45% 45% 50,715,000

45% [ ] 14.8% 51.9% 2.3% 0.27% 25%[ ] 17.2% 27.8% 38,872,000 62,828,000 38.2 8.05 8.05(1)(a) 4.05A (a) 45%

(b) 16(c) (d) 51% 34% 10% 5% API MSPEA III Cayman China Pharma MSPEA Pharma BV(1) China PharmaChina Pharma Plenty Gold

60% 4 60% 20% 1.148 560,000 41% 20% MSPEA III Cayman Plenty Gold69% Plenty Gold 51% 25% 11% 10.1% 2.9% 2.2% 2.1% 1.4% 2% 23.3% MSPEA III Cayman MSPEA Pharma BV China Pharma 0.975 China Pharma

China Pharma MSPEA Pharma BV MSPEA Pharma BV MSPEA III Coop MSPEA III Coop MSPEA III Cayman MSPEA III Cayman MSPEA IIIMSPEA III MSPEA III GP MSPEA III GP MSPEA III Inc. China Pharma 76.6% MSPEA Pharma BV China Pharma (a) MSPEA Pharma BV China Pharma 48,672,331.39 China Pharma (b) China PharmaChina Pharma China Pharma China Pharma 48,672,331.39 MSPEA Pharma BV MSPEA Pharma BV MSPEA Pharma BV 48,672,331.39 47,000,000 10% Plenty Gold MSPEA Pharma BV [ ]

China Pharma Plenty Gold China Pharma 95% China Pharma Plenty Gold... 87.7%... 1.6%... 0.7% MSPEA Pharma BV... 10.0%... 100.0% Plenty Gold Top Matrix Top Matrix Plenty Gold 42,300,000 9% 12.766 540 NHC NHC Top Matrix New Horizon Capital III L.P. NHC NHC NHC Plenty Gold... 78.7%... 1.6%... 0.7% MSPEA Pharma BV... 10.0% Top Matrix... 9.0%... 100.0%

NHC MSPEA Pharma BV (a) Plenty Gold MSPEA Pharma BV Top Matrix Eddy Huang (b) MSPEA Pharma BV Top Matrix (i) Plenty Gold (ii) Plenty Gold (c) MSPEA Pharma BV Top Matrix (d) MSPEA Pharma BV Top Matrix (e) MSPEA Pharma BV NHC Plenty Gold NHC NHC Top MatrixPlenty Gold [ ]Top Matrix Top Matrix [ ] Plenty Gold Top Matrix NHC NHC Top Matrix PlentyGold

Plenty Gold Top Matrix Top Matrix Plenty Gold 42,300,000 127,465,589Top Matrix NHC160% Plenty Gold 73,764,80853,700,781 Plenty Gold Top Matrix [ ] Top MatrixPlenty Gold Plenty Gold MSPEA Pharma BV Top Matrix Top Matrix Top Matrix Plenty GoldMSPEA Pharma BV Top Matrix Top Matrix MSPEA Pharma BV[ ] MSPEA Pharma BV Plenty Gold [ ] 41,212,900 75,200 32,900 Plenty Gold [ ]

Plenty Gold... 77.8%... 1.6%... 0.7% MSPEA Pharma BV... 10.0% Top Matrix... 9.0%... 0.9%... 100.0%

(1) MSPEA Pharma BVMSPEA III Coop MSPEA III Coop MSPEA III Cayman MSPEA III Cayman MSPEA IIIMSPEA III MSPEA III GP MSPEA III GP MSPEA III Inc. (2) Plenty Gold 51% 25% 11% 10.14% 2.86% (3) 61%

IMS 7.2% 7.3% 7.4% 2,000 31 10,000 14 17.1% 20 30 235.6 401.4 560.6 393.0 82.3%, 78.7%, 79.1% 83.0%17.3 46.2 55.5 30.7 6.0% 9.1% 7.8% 6.5% 33.4 61.2 84.8 49.1 11.7% 12.0% 12.0% 10.4% 66.5% 60.1% 57.3% 57.7%

13 19 12 % % % % % (1)... 255,436 89.2 423,123 83.0 549,875 77.6 253,017 78.5 359,110 75.9... 28,996 10.1 76,375 14.9 115,743 16.3 52,465 16.3 75,004 15.8... 1,917 0.7 10,550 2.1 43,289 6.1 16,912 5.2 39,323 8.3... 286,349 100.0% 510,048 100.0% 708,907 100.0% 322,394 100.0% 473,437 100.0% (1) 2,000 31

10,000 89070% 3,600 55% 5,400 278 333 13 30 10 10% GMP GMP

286.3 510.0 708.9 57.4%178.8 233.4 313.7 32.5% 179.3 237.1 326.3 34.9%473.4 247.4 254.8 Sanofi-Aventis Pfizer 17.1% 58.1% 2,000 31 10,000 890 70% 3,60055% 5,400

278 200 2,000 44 1,664 81.8% 4,668

22.9% 44 19 44 12 33311 134 289 44 30 10 10%

15 17 17 20

500 90% 80% 70%

GMPFDA 10010300 30 44 33

14 11 19 4 6 1 3 5 44 (2) (1) (1) (1) (1)

(2) (1) (1) [2007]42 [2009]387 [2010]394 (2) 245.3 432.1 623.6 434.3 14 10453 24.0% 29.2%

0.0093% 510.0051% 2,515 341.35%...... 320 600... 7 14 30... 20

66.5% 60.1% 57.3% 57.7% 493.2 183.4 28.1% 58.1% 120

733.9501.9 10.0% 22.4% GM1 GM1 GM1 GM1 1,869.3 133.3 93.5% GM1 GM1 1,319.5138.2 75.8%

11 661 22.4% 27.1% % % % % %... 4,988 1.7 19,706 3.9 18,609 2.6 9,547 3.0 7,357 1.6... 4,233 0.8 16,130 2.3 7,226 2.2 11,521 2.4... 12,335 4.3 22,290 4.4 20,778 2.9 10,295 3.2 11,781 2.5 12 805.7329.3 25.1% 14.3% 13 1,000.695.6 79.9%

61.9 7.0 72.4% % % % % %... 3,180 1.1 17,096 3.4 36,513 5.2 16,787 5.2 19,523 4.1 (1)... 14,727 5.2 17,270 3.4 16,143 2.3 8,211 2.6 10,436 2.2... 15,534 5.4 26,808 5.3 32,164 4.5 14,827 4.6 19,161 4.1 (1) Feidiao Pudiao Quxinao 1530

1,710.8 552.0 32.7% 238.8%COS Feidiao Pudiao Quxinao 495.0 176.5 29.4% 527.7204.3 26.8% 2,000 10,000 278

278 27 251 50 31 200 2,000 GSP 2,000 89070%3,60055%5,400

GSP (i) (ii) (iii)

0.004% 0.004% GSP GSP

(1) (2) (3) 1,594 1,773 2,398 2,022

30.0% 21.6% 19.6% 16.9% 12.3% 7.4% 6.2% 4.6% 3.9% 14.2% [2010]253 46.7% 10.6% 0.3%

1) 1) 1) 1) 2) 2) 2) 2) 3) 3) 3) 3) 4) 4) 4) 4) 5) 5) 5) 5)

62.4 61.5 61.5 61.5 211.6 197.1 197.1 197.1 80 56 56 50.6 50.6 120 69 69 69 69 359 4 99237 333 11 134 289 10

(i)(ii) (iii) (iv) 23 CCV 171 6 159 44 13 27 26

65.0 36.4 48.2 10%... 286,349 510,048 708,907 473,437... 65,000 36,370 48,203 50,794... 22.7% 7.1% 6.8% 10.7% (1)... 4,394 8,435 13,697 9,137... 2,355 5,851 15,617 9,132... 55,927 14,369 7,264 19,897... 2,324 4,344 5,666 9,941... 3,371 5,959 2,687 (1) 10.76.2

30 10

182.5% EvaluatePharma 12

20 2,800,000 200,000 300,000 300,000 500,000 3,500,000 7,300,000 15,000,000 GMP 25,329 15,305 GMP62.5 3 505608

(1 (%) (%) (%)... 3,000,000 1,760,000 58.7 3,020,000 101.0 (2) 3,030,000 101.0 (2)... 62,500,000 26,810,000 95.7 (3) 35,810,000 57.3 45,270,000 72.4... 50,000,000 49,120,000 98.2 21,100,000 42.2 16,450,000 33.0... 560,000,000 427,000,000 76.2 373,000,000 66.6 337,000,000 60.2... 8,000,000 3,160,000 39.5 6,390,000 80.0 2,030,000 25.4 (1) 250 (2) 100% (3) 2,8006,250 3 27 100 10 300

50 300 84.7% 68.1% 63.6% Harbin Tri-Lion Pharmaceutical Co., Ltd. 25.2% 34.3% 28.0% 51%

21 11 GMP 10 11 11

67.6 156.4 197.1 23.6% 30.6% 27.7% 111.0 23.4% 31.7 93.0 104.0 52.4% 69.6% 54.2% 12 0.7% 2.1% 6.1% 8.3%

26 GSP GMP GMP

28,000 20,000 6,000 GSP GMP

90 84 77 99 233 4 10 20 156 85 10

IMS 3,600 20 24.7% 2.2%

100 BayerSimcere Pharmaceutical GroupGM1 58.1% Hefei Pingguang Pharmaceutical Co., Ltd. 16.4% 22.4% Ebewe Pharma Ges.m.b.H. Nfg. KG 41.7% 5.0% 3.2% Heilongjiang Harbin Medical University Pharmaceutical Co., Ltd. GMIGM159.8% 23.0% 7.9% 14.3% 12.8% 8.8% 13.6% Zhejiang Jianfeng Pharmaceutical Co., Ltd. Guilin Aolin Pharmaceutical Co., Ltd. 46.8% 28.1% 4.3% Beijing Kaiyin Pharmaceutical Co., Ltd. Beijing Huasu Pharmaceutical Co., Ltd. 17.1% 9.9% 5.4% Boehringer Ingelheim International Trading Co., Ltd. Shenyang New Horse Pharmaceutical Co., Ltd. 33.4% 15.4%

72,009.6 20,138.0

23,374.1 153,970.52 500,000 2.85 API 2,931.50 781.5 API 5 API 150,000 API 100,000 50,000 10,000 100,000 100,000 274,557.2 2,178 150,000

65,340 80 80 50 30,000 30 30 3,350.4 480,000 2.8 886,003 144.64 11,000 API

GMP GMP

51 (3) 1. H20020088 H20020125 (4) 80 (1) 2. H20061204 (4) (1) 320 3. (2) Z20050247 Z20055421 0.525 4. H20051134 H20051685 220 (1) 20 (4) 5. (1) H20060556 0.4 6. (1) H20060351 H20060555 1 7. (1) H20060554 2 8. H20055217 60 (4) 9. H20064521 0.25 10. H20055760 22 (4) 11. H20055759 11 (4) 12. H20055758 10.4 (4) 13. H11020127 0.25 14. (1) H20051024 H20051518 0.3 15. (1) H20051023 H20051517 16. H20058155 0.25 17. H20063944 60 18. H20066943 40

(3) 19. H20063941 20 20. H20063942 80 21. H20044990 1.2 110 (4) 22. H20093221 10 23. H20073958 20 24. H20073971 40 25. H20074007 80 26. H20083224 220 27. H20080100 0.25 1.25 28. H20084309 40 29. H20084310 80 30. (1) H20080046 H20080102 0.5 31. H20080401 50 32. H20056285 0.25 33. H20059159 34. H20067160 35. H20064033 36. H20084282 2 37. H20084283 4

(3) 38. H20084284 8 39. H11020128 0.1 (4) 40. H11020125 10 (4) 41. H11020126 0.1 (4) 42. H11020121 80 43. H11020123 1 44. H11020124 2 (4) 45. H20000671 3 46. (1) (1999)X-28 H19991046 0.1 47. H20055755 40 (5) 48. H20055757 49. H11020122 50. H20020124 51. H20103399 (1) 1 4 6 14 1530 46 (2) (3) (4)

(3) 1. H20020268 H20020386 (2) 50 (4) H20051062 0.1 (4) H20051063 0.2 (4) 2. (1) H20030414 H20030553 0.12 (4) H20041175 80 (4) H20041171 40 (4) 3. (2) H20051206 H20051750 10 (4) H20051751 20 (4) 4. H20030570 H20030735 0.15 (2) (4) 5. 1 H20055557 2 1 (4) H20055558 2 (4) 6. H20065159 0.5 H20065160 1 7. Z20026460 (4) 8. (2) Z20050167 Z20050158 (4) 9. (2) H20050661 H20050987 0.3 (4) H20050988 0.6 (4) 10. (2) H20050935 H20051202 (4)

(3) 11. 1.5 3 H20040716 0.75 1.5 (4) 2.25 H20044347 3 (4) 2:1 H20044346 (0.75 ) (4) H20045273 2.25 (4) 12. 0.5 1 H20043923 2 1 (4) H20045271 0.5 (4) H20045272 2 (4) 13. H20080049 H20080106 (2) 14. H20070005 1 15. H20084170 0.75 H20084172 1.5 16. H20040620 H20060214 (2) (4) 17. H20034162 100 (4) H20034161 200 (4) 18. H20057878 530 H20057879 1060 19. 1080 H20054513 1070 1080 (4) H20054512 1070 (4) 20. (2) H20051764 H20052581

(3) 21. H20056325 (4) 22. H20068014 (4) 23. H20067414 80 H20067415 60 H20066943 20 24. ( ) H20080592 2030 25. H20070034 0.25 (4) H20056297 0.5 (4) H20056298 1 (4) H20056295 1.5 (4) H20056296 2 (4) 26. H20044468 0.5 (4) H20058717 1 (4) H20058718 2 (4) 27. H20063806 2 28. H20054704 24 (4) 29. H20045991 1 (4) 30. ( H20060154 ) 15 H20060155 30 31. H20056134 40 (4) 32. Z20025400 0.28 (4)

(3) 33. H20052588 10 34. H20084087 0.25 35. H20084086 0.1 36. H20084383 0.5 37. H20084384 1 38. H20084032 530 39. H20084033 16.7100 40. H20093094 0.2 (1) (2) (3) (4) API

[2007]42 [2009]387 [2010]394

GMP Jing G0153 L5157 Jing G0181 Jing I0275 I4396 Jing J0356 GMP

12 300,000 (i) 122(1) (ii) 122(1A) China Pharma 2,019,922 131,600 China Pharma China Pharma China Pharma

China Pharma [2006]27 [1999]30 18 50% 18% 20% 22%2007(39) 11%22% [2007] 39 [2007]39 [2009]69 [2009]69 [2007]39 25% [2009]69[2007]39 12.5%

[2010]15715% 12.5% 15% 9% 10% 11%... 33% 25% 25% 25% (1)... 7.5% 15% 15% 15% (2)... 12.5% 12.5% 12.5% (3)... 7.5% 18% 20% 22% (4)... 7.5% 9% 10% 11% (1) (2010)15715% (2) (2009)69 (3) (2007)39 (4)

15% 23,800,000 60 60 10,000 200,000

395 598 841 181 21.5% 266 31.6% 189 22.5% 131 15.6% 74 8.8% 841 100% 1.1 - (i) (ii) (iii)

(iv)

Plenty Gold [ ] [ ] [ ][ ]

(i) (ii) 5% (i) 30%; (ii) (iii) (i) (ii)

(iii) (i) (iv) (v) (vi) (vii) (i) 30% (ii)

[ ]... 47... 46... 46... 48... 39 Eddy Huang... 35... 51... 67... 68 47 8 17

46 17 177 46 7

48 39 Morgan Stanley Private Equity Asia 691 China Flooring Holding Company Limited Morgan Stanley Private Equity Asia Simpson Thacher & Bartlett Eddy Huang35 Morgan Stanley Private Equity Asia Eddy Huang Morgan Stanley Private Equity Asia

Financial Institutions Investment Banking Group CIMIC Industrial Group Ltd. 002162 51 Solomon Systech International Limited 2878 390 891 821 188 67

002219 68 (i) (ii) (iii)13.51(2)(h) 13.51(2)(v) (iv) (v) 13.51(2)

... 41... 43... 51... 35... 45... 40... 41... 53... 46 () 41 Shenzhen Tong Yun Group 43 20 100 51 Wuhan Ma Ying Long Pharmaceutical Co., Ltd.Wuhan Ma Ying Long Chained Pharmacies Co., Ltd. 35 Titan Chemicals Corp. Bhd.

Titan Petrolchemicals (M) Sdn. Bhd. Nelson PolytechnicNelson Marlborough Institute of Technology 45 7 40 41 53 46

15 48 1338 3998 1186 817 1238 631 1308 3337 3355 1202 1618 705 2006 SOHO 410 811

1818 1099 220 2168 1886 916 325 2601 TJCC IMM 1683 2310 1021 1918 3.21 14 C3

B1 5.4 8.8 14.1 9.7 0.8 0.9 1.0 3.0

13 985... 181 18.4%... 266 27.0%... 333 33.8%... 131 13.3%... 74 7.5%... 985 100% Plenty Gold [ ] Plenty Gold [ ]

[ ] Plenty Gold 4,230,000 30% [ ] 2 BC 89

[ ] [ ]%

7.2% 7.3% 7.4% 2,000 31 10,000 286.3 510.0 708.9 57.4% 178.8 233.4 313.7 32.5% 179.3 237.1 326.3 34.9% 473.4 247.4 254.8 IMS 1,072 2,439 22.8%

8,500 IMS 6,913 23.2% IMS (i) (ii)(iii) (iv) (v) IMS 285 120 24.1% 36.4%IMS 44 104 24.0%

(i) (ii) 21 23.6% 30.6% 27.7% 23.4% 2,000 31 10,000 278

(i) (ii) 30 10 (i)(ii) (iii) (iv) 44 19

44 31 93.8% 85.8% 81.5% 80.6%

4 2

10.0% 0.83 0.33 0.53 0.68 0.83 0.33 0.53 0.68

82.3% 78.7% 79.1% 83.0% 241.0 396.3 540.0 370.3 84.1% 77.7% 76.2% 78.2% % % % % %... 177,505 62.0 258,822 50.8 330,864 46.7 148,203 46.0 215,899 45.6... 13,010 4.5 47,523 9.3 75,252 10.6 35,606 11.0 57,018 12.1... 29,140 10.2 49,580 9.7 63,080 8.9 29,554 9.2 41,809 8.8 (1)... 4,581 1.6 23,126 4.5 37,176 5.2 19,369 6.0 24,303 5.1... 1,775 0.4 22,837 3.2 7,877 2.4 31,277 6.6... 12,383 1.8 4,342 1.4 12,746 2.7... 11,349 4.0 20,539 4.0 19,029 2.7 9,849 3.0 9,956 2.1... 235,585 82.3 401,365 78.7 560,621 79.1 254,800 79.0 393,008 83.0... 4,233 0.8 16,130 2.3 7,226 2.2 11,521 2.4... 1,821 0.6 9,060 1.8 9,321 1.3 4,695 1.5 3,695 0.8... 2,474 0.9 8,329 1.6 7,770 1.1 3,999 1.2 3,345 0.7... 693 0.2 2,317 0.5 1,518 0.2 853 0.3 317 0.1... 12,335 4.3 22,290 4.4 20,778 2.9 10,295 3.2 11,781 2.5... 17,323 6.0 46,229 9.1 55,517 7.8 27,068 8.4 30,659 6.5

% % % % % (2)... 14,727 5.2 17,270 3.4 16,143 2.3 8,211 2.6 10,436 2.2... 2,935 1.0 16,349 3.2 33,642 4.8 15,506 4.8 17,607 3.7... 245 0.1 747 0.1 2,870 0.4 1,281 0.4 1,916 0.4... 15,534 5.4 26,808 5.3 32,164 4.5 14,827 4.6 19,161 4.1... 33,441 11.7 61,174 12.0 84,819 12.0 39,825 12.4 49,120 10.4 (3)... 1,280 0.2% 7,950 1.1% 700 0.2% 650 0.1%... 286,349 100% 510,048 100% 708,907 100% 322,394 100% 473,437 100% (1) (2) Feidiao Pudiao Quxinao (3) 219.7 355.9 469.2 76.7% 69.8% 66.2% 66.5% 66.2% 4.6 23.1 37.2 184.9% 24.3 19.425.5% 35.2 44.0 5.0% 9.3% 4.2 16.1 281.1% 11.5 7.259.4%

2.9 16.3 33.6 238.6% 10.4 8.227.1% 17.6 15.513.5% (i) (ii) (iii) (3)... 75.7% 67.3% 66.2% 65.0% 68.3%... 23.6% 30.6% 27.7% (1) 29.8% 23.4% (1) (2)... 0.7% 2.1% 6.1% 5.2% 8.3%... 100.0% 100.0% 100.0% 100.0% 100.0% (1) (2) (3)

30.0% 21.6% 19.6% 16.9% 12.3% 7.4% 6.2% 4.6%

... 33,215 54.9 97,389 72.9 138,896 72.4 65,355 72.1 90,863 71.5... 17,989 29.7 24,940 18.7 41,514 21.6 19,883 21.9 30,846 24.3... 7,438 12.3 8,813 6.6 8,769 4.6 3,785 4.2 3,375 2.7... 1,884 3.1 2,409 1.8 2,736 1.4 1,673 1.8 1,990 1.5... 60,526 100% 133,551 100% 191,915 100% 90,696 100% 127,074 100% 225.8 376.5 517.0 78.9% 73.8% 72.9% 346.4 231.7 73.2% 71.9% (i) (ii)

% % % % %... 204,065 86.6 339,273 84.5 (1) 456,535 81.4 (1) 208,499 81.8 316,628 80.6 (1)... 21,758 42.9 37,224 34.2 60,457 40.8 23,199 34.3 29,735 37.0... 225,823 78.9 376,497 73.8 516,992 72.9 231,698 71.9 346,363 73.2 (1) 1.3% 0.6% 0.6% 0.2%

... 3,717 3,149 4,393 1,458 945... 6,969 12,076 19,453 9,577 18,226... (930) (22,805) (80,261) (80,261)... 38,201 38,201... 13,252... (1,535) (238)... (1,737) (1)... (264) 2,838 2,104 1,874 273... 22,744 (8,014) (16,348) (29,151) 19,444 (1)... (22,732) (38,906) (48,810) (22,634) (26,364)... (38,856) (53,405) (78,809) (35,276) (52,420)... (2,527) 470 5,644 177 3,072... (64,115) (91,841) (121,975) (57,733) (75,712)

22.7 38.9 48.8 26.4 7.9% 7.6% 6.9% 5.6%... 18,776 29,386 33,674 16,032 15,685... 2,265 3,771 7,304 3,125 4,301... 1,464 4,402 6,752 2,840 3,745 (1)... 227 1,347 1,080 637 2,633... 22,732 38,906 48,810 22,634 26,364 (1) 4.0% 3.8% 3.3% 3.2%

60% 38.9 53.4 78.8 52.4 13.6% 10.5% 11.1% 11.1%... 4,394 8,435 13,697 4,031 9,137... 10,280 18,877 26,594 13,712 17,820... 7,627 8,258 13,471 5,007 6,113... 2,822 7,799 10,473 4,332 3,872... 7,989 4,134 4,217 1,203 4,599 (1)... 5,744 5,902 10,357 6,991 10,879... 38,856 53,405 78,809 35,276 52,420 (1) 0.9% 0.1% 0.8% 0.6%

... (3,622) (3,706) (493) (1,053) (1,039)... 1,271 4,259 6,236 1,287 4,157... (176) (83) (99) (57) (46)... (2,527) 470 5,644 177 3,072 45.0% 10.4 2.4 3.1% 18.7% 17.7% 14.7% 15.0% 25.0% 15.0% 15.0% 11.5

0.4 3.6 12.7 7.4 322.4 46.9%473.4 254.8 54.2%393.0 (i)(ii) 148.2 45.7%215.9 35.6 60.1% 57.0 29.6 41.5% 41.8 19.4 25.5% 24.3 9.3% 3.8% 66.9 19.3%79.8 7.2 59.4%11.5 8.2 27.1%10.4

4.7 21.3% 3.7 4 17.5% 3.3 90.7 40.1% 127.1 231.7 49.5% 346.4 71.9% 73.2% (i) (ii) 29.2 19.4 9.6 90.3% 18.2 80.3 38.2 22.6 16.5% 26.4 7.0% 5.6% 35.3 48.6% 52.4

15.9 22.6 6.3 9.1 0.2 3.1 2.9 2.4 147.2 97.1%290.1 36.3 17.5%42.7 24.7% 14.7% 110.8 123.2%247.4 119.6 113.1%254.8

8.8 15.1%7.4 510.0 39.0% 708.9 401.4 39.7% 560.6(i) (ii) (iii) 258.8 27.8% 330.9 47.5 58.3% 75.3 49.6 27.2% 63.1 23.1 60.8% 37.2 5.0%0.4% 107.4 30.7% 140.3 57.2% 4.2 281.1% 16.1 16.3 105.8% 33.6

17.3 6.5% 16.1 Quxinao 133.6 43.7% 191.9 376.5 37.3% 517.0 73.8% 72.9% 8.0 104.0% 16.3 80.3 38.2 38.9 25.5% 48.8 7.6%6.9%

53.4 47.6% 78.8 8.4 13.7 0.5 5.6 3.7 0.5 2.0 10.4 77.4% 2.4 287.1 32.7% 381.0 53.6 25.7% 67.4 18.7% 17.7% 233.4 34.4% 313.7

237.1 37.7% 326.3 3.6 252.8% 12.7 286.3 78.1% 510.0 113.0 235.6 70.4% 401.4(i) (ii) 177.5 45.8% 258.8 13.0 265.3% 47.5 29.1 70.1% 49.6 219.3% 4.6 404.8% 23.1 50.8 111.6% 107.4 11.0% 60.5 120.8% 133.6

225.8 66.7% 376.5 78.9% 73.8% 22.7 8.0 22.8 1.7 12.13.1 22.8 22.7 71.2% 38.9 7.9% 7.6% 38.9 37.4% 53.4 1.9 2.0 4.7 9.35.7

2.5 0.5 1.3 4.3 0.2 0.1 45.0% 10.4 184.5 55.6% 287.1 5.6 53.6 (i)15.0% 7.5%15% (ii) 6.7 11.5 3.1% 18.7% 178.8 30.5% 233.4 179.3 32.2% 237.1 0.4 800.0% 3.6

262.4 331.2 612.9 620.4 214.5 314.8 577.7 800.3 12 12.0... 182,565 256,819 385,648 171,334 183,984... (155,731) (115,365) 16,062 61,098 (2,526)... 193,758 (72,656) (120,029) (71,558) (173,939)... 41,788 262,380 331,178 331,178 612,859... 262,380 331,178 612,859 492,052 620,378

184.0 241.9 57.9 302.7 60.8 6.327.3 27.1 385.6 438.9 53.3 443.4 4.4 3.6 37.7 36.8 256.8 282.9 26.0 323.1 40.2 16.4 40.1 16.3 182.6 193.7 11.2 185.5 8.2

9.5 1.4 19.2 2.5 (i) 20.1 (ii)18.6 (i)45%32.0 (ii) 4.2 16.1 45.0% 69.7 14.7 6.2 (i)56.7 (ii)8.3 (iii) 48.3 (1) 6.0 (iv)3.7 115.4 (i)39.8 (a) 61.9 (2) 31.9 (b) 48.3 (1) 6.0 (c) 1.9 (3) (ii) 35.7(iii)29.5

(iv)14.6 4.3 155.7 (i)55.9 (ii)45.0(a) 61.9 (2) 30.0 (b)15.0 (iii) 48.3 (1) 36.3 (iv)30.8 37.9 173.9 China Pharma 173.9 120.0 120.0 72.7 60.7 12.0 193.8 197.8 4.0 (1) 48.360.0 11.7 (2) 61.9 62.5 0.6 (3) 1.93.8 1.9

86.8 44.1 68.7 38.7... 30,839 29,452 56,677 18,580... 55,927 14,624 8,295 20,122... 3,738... 86,766 44,076 68,710 38,702 214.5 314.8 577.7 800.3... 22,953 39,395 42,967 49,298... 24,714 71,424 141,132 310,519... 262,380 331,178 612,859 620,378... 310,047 441,997 796,958 980,195... 68,826 89,551 120,391 94,261... 14,693 37,643 98,869 85,663... 12,000... 95,519 127,194 219,260 179,924... 214,528 314,803 577,698 800,271

35.0 55.9 14.4 7.3 19.9 1.0 24.3 45.1 30.8 29.5 56.7 18.6

10.4 2.4 24.7 71.4 141.1 310.5... 3,119 4,228 2,542 2,989 (1)... (138) (138) (138) (138)... 2,981 4,090 2,404 2,851 (2)... 6,289 27,202 63,878 87,001 (3)... 15,444 40,132 42,850 46,728 (4)... 173,939... 32,000... 24,714 71,424 141,132 310,519 (1) (2) (3) (4) China Pharma China Pharma [ ] China PharmaChina Pharma

30 0.1 0.1 0.1 0.1 4.4% 3.3% 5.4% 4.6% 6.3 27.2 63.9 87.0 15.440.1 42.946.7 32.0

... 8,267 7,761 17,876 13,851... 936 1,100 4,235 3,787... 13,750 30,534 20,856 31,660... 22,953 39,395 42,967 49,298 23.0 39.4 43.0 49.3 13.8 30.5 30.5 20.9 20.9 31.7 7.8 17.9 17.9 13.9

68.8 89.6 120.4 94.3 (1)... 8,859 4,187 12,675 8,526... 2,250 2,938 1,370 33 (2)... 13,671 20,804 49,535 18,847... 3,959 7,157 8,652 18,635... 12,000 6,000 (3)... 3,690 7,044 12,000 20,950 (4)... 2,354 (5)... 24,397 39,067 36,159 27,270... 68,826 89,551 120,391 94,261 (1) (2) (3) 21.0 12.0 [ ]9.0 (4) (5) 8.9 4.2

4.2 12.7 12.7 8.5 13.7 20.8 49.5 49.5 18.9 (1)... 7 3 2 1 (2)... 90 84 77 65 (3)... 33 18 16 15 (1) 360 (2) 360 (3) 360 90 84 77 65

33 18 16 15 1 1 2 2 5 5 (1)... 1,436 659 271 506 (2)... 23,089 23,089 (3)... 2,739 2,739... 27,264 3,398 23,360 506 (1) (2) (3)

12 60.7 120.0

545.7

3.340 I IV II10 9

3.340 I IV II2 2410 II2

I. 6 78,675 117,287 162,036 173,127 7 190,248 225,391 137,461 150,817 8 6,576 16,234 18,843 18,279 9 61,142 19 58,144 40,937 11 45,000 320,499 420,054 376,484 383,160 12 22,953 39,395 42,967 49,298 13 24,714 71,424 141,132 310,519 14 262,380 331,178 612,859 620,378 310,047 441,997 796,958 980,195 630,546 862,051 1,173,442 1,363,355 15 69,262 69,262 69,262 69,262 15 182,909 182,909 182,909 182,909 16 45,626 75,255 109,585 109,585 16 227,016 373,790 545,747 800,596 524,813 701,216 907,503 1,162,352 14,644 16,684 10,318 524,813 715,860 924,187 1,172,670 19 10,214 18,997 29,995 10,761 17 68,826 89,551 120,391 94,261 24 14,693 37,643 98,869 85,663 18 12,000 95,519 127,194 219,260 179,924 105,733 146,191 249,255 190,685 630,546 862,051 1,173,442 1,363,355 214,528 314,803 577,698 800,271 535,027 734,857 954,182 1,183,431

10 208,617 208,617 208,617 208,617 13 27,002 36,349 35,049 35,891 14 82,244 49,396 26,258 19,880 109,246 85,745 61,307 55,771 317,863 294,362 269,924 264,388 15 69,262 69,262 69,262 69,262 15 182,909 182,909 182,909 182,909 16 50,781 24,283 (4,554) (18,774) 302,952 276,454 247,617 233,397 17 14,911 17,908 22,307 30,991 14,911 17,908 22,307 30,991 317,863 294,362 269,924 264,388 94,335 67,837 39,000 24,780 302,952 276,454 247,617 233,397

20 286,349 510,048 708,907 322,394 473,437 21 (60,526) (133,551) (191,915) (90,696) (127,074) 225,823 376,497 516,992 231,698 346,363 20 22,744 (8,014) (16,348) (29,151) 19,444 21 (22,732) (38,906) (48,810) (22,634) (26,364) 21 (38,856) (53,405) (78,809) (35,276) (52,420) 186,979 276,172 373,025 144,637 287,023 23 1,271 4,259 6,236 1,287 4,157 23 (3,798) (3,789) (592) (1,110) (1,085) (2,527) 470 5,644 177 3,072 9 10,427 2,357 2,357 184,452 287,069 381,026 147,171 290,095 24 (5,626) (53,621) (67,370) (36,335) (42,683) 178,826 233,448 313,656 110,836 247,412 179,266 237,059 326,316 119,594 254,849 (440) (3,611) (12,660) (8,758) (7,437) 178,826 233,448 313,656 110,836 247,412 25 39.93 50.44 69.43 25.45 54.22

54,413 24,775 68,601 2,661 150,450 179,266 (440) 178,826 15 14,849 193,338 208,187 15 (10,429) (10,429) 29(b) (2,221) (2,221) 16 20,851 (20,851) 69,262 182,909 45,626 227,016 524,813 69,262 182,909 45,626 227,016 524,813 237,059 (3,611) 233,448 18,255 18,255 26 (60,656) (60,656) 16 29,629 (29,629) 69,262 182,909 75,255 373,790 14,644 715,860 69,262 182,909 75,255 373,790 14,644 715,860 326,316 (12,660) 313,656 14,700 14,700 26 (120,029) (120,029) 16 34,330 (34,330) 69,262 182,909 109,585 545,747 16,684 924,187 69,262 182,909 109,585 545,747 16,684 924,187 254,849 (7,437) 247,412 1,071 1,071 69,262 182,909 109,585 800,596 10,318 1,172,670 69,262 182,909 75,255 373,790 14,644 715,860 119,594 (8,758) 110,836 26 (71,558) (71,558) 69,262 182,909 75,255 421,826 5,886 755,138

27 193,715 282,901 438,938 198,135 241,900 (11,150) (26,082) (53,290) (26,801) (57,916) 182,565 256,819 385,648 171,334 183,984 9 (35,715) 9 69,700 69,700 32,000 11 (45,000) 29 (36,305) (39,833) (6,000) 19 14,700 29 (2,485) 27 302 136 (24,684) 37,936 (30,839) (29,452) (56,677) (5,049) (18,580) (55,927) (14,624) (8,295) (4,840) (20,122) (3,738) 1,271 4,259 6,236 1,287 4,157 (155,731) (115,365) 16,062 61,098 (2,526) (173,939) 197,758 (60,656) (120,029) (71,558) (4,000) (12,000) 193,758 (72,656) (120,029) (71,558) (173,939) 220,592 68,798 281,681 160,874 7,519 41,788 262,380 331,178 331,178 612,859 14 262,380 331,178 612,859 492,052 620,378

II. 1. China Pharma Limited China Pharma China Pharma Plenty Gold Enterprises Limited Plenty Gold Clarendon House, 2 Church Street, P.O. Box HM 1022, Hamilton HM DX, Bermuda 85 26-27 570105 (a) 12,000 12,000 1.00 Plenty Gold Plenty Gold Plenty Gold51% 25% 11% 13% 12,000 12,000,000 12,000 7,500,000 Plenty Gold (b) 51% 25% 11% 13% 58,617,000 Hainan Sanpu Pharmaceutical Development Co., Ltd Hainan Sanpu

(c) Hainan Sanpu Hainan Sanpu Hainan Sanpu (d) 1 5012,000,000 600,000,000 0.02 7,500,000 375,000,000 0.02 208,187,00095,000,000 9,400,000 470,000,000 0.02 (e) 2,485,000 49% 51% 100% (f) 60,000,000 (g) 1 11 (h) 3,758,000

(i) 62,500,00060% (j) 50,715,000 45% 101,700,000 45% (k) China Pharma 0.975 China Pharma (l) 51% (m) (n) (o) 4,000,000 60% (p) 61% 41% 20%

% % % % % 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 51 100 100 100 100 100 100 100 100 100 60 60 60 60 100 100 100 100 51 51 51 60 60 100 100 60 60

2. 2.1 4 9

9 2.2 (a) (b)

(b) 2.5 10-35 3-10 3-10 4-10 2.8

2.6 (a) (b) (i) (ii) (iii) (iv) 5 10

2.10 2.11 2.12 2.13 2.14 2.15 2.16

2.17 2.18

2.19 (a) (b) (c) 2.20 2.21

3. 3.1 (a) (i) 14 (ii) (iii)

262,231 149 262,380 331,044 134 331,178 612,786 73 612,859 620,215 163 620,378 (b)

3.3 4. (a) 10% 826,000 325,000 530,000 678,000 826,000 325,000 530,000 678,000

(b) 2.8 35,117,000 12,130,000 49,107,000 13,990,000 15,933,000 7 (c) (d) 5.

6. 48,189 14,757 1,622 5,605 4,056 74,229 (14,978) (4,611) (652) (996) (21,237) 33,211 10,146 970 4,609 4,056 52,992 33,211 10,146 970 4,609 4,056 52,992 29 80 335 93 508 1,150 4,761 593 1,534 22,801 30,839 2,471 (2,471) (302) (302) (2,733) (1,699) (327) (603) (5,362) 34,179 13,208 1,571 5,331 24,386 78,675 51,890 19,518 2,550 6,530 24,386 104,874 (17,711) (6,310) (979) (1,199) (26,199) 34,179 13,208 1,571 5,331 24,386 78,675 34,179 13,208 1,571 5,331 24,386 78,675 29 16,547 478 18 477 17,520 3,864 3,375 1,156 2,630 18,427 29,452 18,136 1,451 493 (20,080) (30) (30) (4,354) (2,551) (545) (880) (8,330) 68,372 15,931 2,693 7,558 22,733 117,287

92,740 25,018 4,431 9,646 22,733 154,568 (24,368) (9,087) (1,738) (2,088) (37,281) 68,372 15,931 2,693 7,558 22,733 117,287 68,372 15,931 2,693 7,558 22,733 117,287 31,069 6,849 1,317 1,548 15,894 56,677 874 (874) (21) (185) (28) (234) (6,458) (3,398) (922) (916) (11,694) 92,962 19,197 3,934 8,190 37,753 162,036 123,681 30,631 6,220 11,194 37,753 209,479 (30,719) (11,434) (2,286) (3,004) (47,443) 92,962 19,197 3,934 8,190 37,753 162,036 92,962 19,197 3,934 8,190 37,753 162,036 29 10 10 683 10,347 731 1,794 5,025 18,580 31,537 187 3 (31,727) (4) (46) (50) (3,893) (2,280) (435) (841) (7,449) 121,289 27,457 4,233 9,097 11,051 173,127 155,901 41,152 6,954 12,917 11,051 227,975 (34,612) (13,695) (2,721) (3,820) (54,848) 121,289 27,457 4,233 9,097 11,051 173,127

3,525 4,067 4,017 2,032 1,875 17 32 23 10 13 1,820 4,231 7,654 4,630 5,561 5,362 8,330 11,694 6,672 7,449 7. 294 30,151 57,186 1,222 88,853 (17,644) (146) (17,790) 294 12,507 57,186 1,076 71,063 294 12,507 57,186 1,076 71,063 29 11,836 28,000 33,000 72,836 230 55,697 55,927 494 (494) (b) (930) (930) (1,400) (7,150) (98) (8,648) 12,130 26,600 39,081 111,459 978 190,248 12,130 28,000 63,875 112,389 1,222 217,616 (1,400) (24,794) (244) (26,438) (930) (930) 12,130 26,600 39,081 111,459 978 190,248

12,130 26,600 39,081 111,459 978 190,248 29 36,977 31,000 67,977 9,089 5,280 255 14,624 (a) (6,000) (6,000) 125 (125) (1,535) (1,535) (b) (2,800) (20,005) (22,805) (5,600) (11,008) (510) (17,118) 49,107 21,000 34,487 120,074 723 225,391 49,107 28,000 73,089 141,009 1,477 292,682 (7,000) (35,802) (754) (43,556) (2,800) (20,935) (23,735) 49,107 21,000 34,487 120,074 723 225,391 49,107 21,000 34,487 120,074 723 225,391 540 6,724 1,031 8,295 1,965 (1,965) (238) (238) (b) (35,117) 1,737 (46,881) (80,261) (5,600) (9,971) (155) (15,726) 13,990 15,400 28,758 77,952 1,361 137,461 49,107 28,000 75,594 145,768 2,253 300,722 (12,600) (45,773) (892) (59,265) (35,117) (1,063) (67,816) (103,996) 13,990 15,400 28,758 77,952 1,361 137,461 13,990 15,400 28,758 77,952 1,361 137,461 29 1,943 1,943 10,000 9,897 225 20,122 (2,800) (5,777) (132) (8,709) 15,933 12,600 32,981 87,849 1,454 150,817

51,050 28,000 85,594 155,665 2,478 322,787 (15,400) (51,550) (1,024) (67,974) (35,117) (1,063) (67,816) (103,996) 15,933 12,600 32,981 87,849 1,454 150,817 (a) 6 (b) 12,000,000 7,150 11,008 9,971 5,687 5,777 1,498 6,110 5,755 2,878 2,932 8,648 17,118 15,726 8,565 8,709

294 294 294 294 11,836 13,696 13,696 13,696 35,117 1,943 12,130 49,107 13,990 15,933 48% 46% 37% 12% 15% 15% 44% 41% 50% 37% 12% 48% 15% 15% 30% 45% 40% 37% 12% 15% 15% 31% 37% 37% 12% 15% 15%

8. 7,982 (1,024) 6,958 6,958 (382) 6,576 7,982 (1,406) 6,576 6,576 29 10,600 (942) 16,234 18,582 (2,348) 16,234

16,234 3,738 (1,129) 18,843 22,320 (3,477) 18,843 18,843 (564) 18,279 22,320 (4,041) 18,279 50 9. 50,715 10,427 61,142 2,357 (63,499) 45% 50,715,000 15,000,000 11 19,231,000

45% 101,700,000 38,201,000 20 476,851 395,735 1,036,068 31,649 45% 10. 208,617 208,617 208,617 208,617 1 11. 30,000,000 29 15,000,000 9 12. 8,267 7,761 17,876 13,851 936 1,100 4,235 3,787 13,750 30,534 20,856 31,660 22,953 39,395 42,967 49,298

50,251,000 113,702,000 170,885,000 77,556,000 112,030,000 13. 3,119 4,228 2,542 2,989 (138) (138) (138) (138) 2,981 4,090 2,404 2,851 6,289 27,202 63,878 87,001 15,444 40,132 42,850 46,728 390 379 701 173,939 1,238 32,000 27,002 35,959 34,670 33,952 24,714 71,424 141,132 310,519 27,002 36,349 35,049 35,891 China Pharma China Pharma China Pharma III

12 3 2,795 3,868 2,160 2,627 3 6 68 35 56 60 6 12 53 123 113 54 12 203 202 213 248 3,119 4,228 2,542 2,989 186,000 222,000 244,000 224,000 3 6 68 35 56 60 6 12 53 123 113 54 12 65 64 75 110 186 222 244 224 138,000 138,000 138,000 138,000 138,000 138,000 138,000 138,000 12 138 138 138 138

111 138 138 138 27 138 138 138 138 14. 149 134 73 163 262,231 181,044 572,786 456,215 82,244 49,396 26,258 19,880 150,000 40,000 164,000 262,380 331,178 612,859 620,378 82,244 49,396 26,258 19,880 1.63% 1.85% 2.74%

180,136 281,782 586,555 595,345 82,226 49,380 11,648 7,119 82,226 49,380 11,602 7,098 13,859 17,700 13,859 12,568 18 16 797 214 18 16 797 214 262,380 331,178 612,859 620,378 82,244 49,396 26,258 19,880 0.25% 0.99% 0.81% 0.97% 15. 12,000 12,000 7,500 54,413 54,413 588,000 367,500 95,000 14,849 193,338 208,187 (10,429) (10,429) 600,000 12,000 470,000 69,262 182,909 252,171 12,000 12,000 1 12,000,000 12,000,000 1 7,488,000 1

1 5012,000,000 600,000,000 0.02 7,500,000 375,000,000 0.02 208,187,00095,000,000 9,400,000 470,000,000 0.02 16. 24,775 68,601 93,376 179,266 179,266 20,851 (20,851) 45,626 227,016 272,642 237,059 237,059 (60,656) (60,656) 29,629 (29,629) 75,255 373,790 449,045 326,316 326,316 (120,029) (120,029) 34,330 (34,330) 109,585 545,747 655,332 254,849 254,849 109,585 800,596 910,181 75,255 373,790 449,045 119,594 119,594 (71,558) (71,558) 75,255 421,826 497,081

(1,097) 50,781 24,283 24,283 (4,554) 51,878 34,158 91,192 49,616 (14,220) (60,656) (120,029) (71,588) 50,781 24,283 (4,554) 2,311 (18,774) 10% 50% 17. 8,859 4,187 12,675 8,526 2,250 2,938 1,370 33 1,194 837 280 13,671 20,804 49,535 18,847 3,959 7,157 8,652 18,635 12,000 6,000 3,690 7,044 12,000 20,950 3,690 7,044 12,000 20,950 2,354 24,397 39,067 36,159 27,270 14 10,027 10,027 10,027 10,027 68,826 89,551 120,391 94,261 14,911 17,908 22,307 30,991

6 6,678 3,034 10,800 7,445 6 12 1,631 6 645 12 550 1,147 1,230 1,081 8,859 4,187 12,675 8,526 18. 12,000

19. 1 58,144 40,937 1 (8,474) (9,031) (22,469) 4,584 1 (1,740) (9,966) (7,526) 6,177 (10,214) (18,997) (29,995) 10,761 (10,214) (18,997) 28,149 30,176 (683) (10,214) (18,997) (18,997) 28,149 29 (9,561) (4,194) 24 30 (4,589) 47,146 (2,089) 2,027 (10,214) (18,997) 28,149 (21,086) 30,176

683 683 29 9,561 9,561 24 (30) (30) 10,214 10,214 10,214 10,214 29 4,194 4,194 24 (2,156) 6,745 4,589 12,252 6,745 18,997 12,252 6,745 18,997 24 (2,287) 13,285 10,998 9,965 20,030 29,995 9,965 20,030 29,995 24 (1,234) (18,000) (19,234) 8,731 2,030 10,761 10%

6,745,000 20,030,0002,030,000 166,007,000 279,368,000 306,486,000 (a)24 58,144 58,144 58,144 24 (17,207) 40,937 (a) 4,084,000 6,200,000 29,459,000 24,219,000 1,021,000 1,550,000 7,365,000 6,055,000 4,084,000 6,200,000 29,219,000 24,219,000

20. 286,349 510,048 708,907 322,394 473,437 3,717 3,149 4,393 1,458 945 6,969 12,076 19,453 9,577 18,226 7 (930) (22,805) (80,261) (80,261) 9 38,201 38,201 13,252 7 (1,535) (238) (1,737) (264) 2,838 2,104 1,874 273 22,744 (8,014) (16,348) (29,151) 19,444

21. 4,394 8,435 13,697 4,031 9,137 7 7,150 11,008 9,971 5,687 5,777 11,544 19,443 23,668 9,718 14,914 6 5,362 8,330 11,694 6,672 7,449 8 382 942 1,129 564 564 7 1,498 6,110 5,755 2,878 2,932 66,024 130,144 164,342 75,301 122,386 (15,773) (16,442) 6,543 2,255 (10,356) 22 12,734 25,872 37,369 18,578 28,927 10,394 10,472 12,478 4,661 6,793 20,083 21,214 27,977 13,023 11,276 2,973 4,902 2,060 1,209 536 2,399 4,379 5,562 2,375 3,657 2,375 1,974 3,233 1,357 1,928 1,378 670 1,882 886 1,019 2,288 4,429 3,459 5,499 741 5,564 11,413 5,670 8,334 122,114 225,862 319,534 148,606 205,858

22. 11,153 22,141 33,595 16,084 25,417 771 2,054 2,423 1,426 1,261 810 1,677 1,351 1,068 2,249 12,734 25,872 37,369 18,578 28,927 (a) (b) 640 1,845 4 377 1,107 225 738 205 205 410 1,242 3,690 4

750 3,406 4 450 2,044 4 300 1,362 115 36 189 189 378 1,615 6,812 44 750 6,000 4 450 3,600 4 300 2,400 (a) 48 15 (b) 286 (b) 286 572 1,548 12,000 23 (a) (b)

375 4,475 4 225 2,685 4 150 1,790 750 8,950 8 375 3,000 2 225 1,800 2 150 1,200 a 48 15 (b) 134 (b) 134 268 798 6,000 19 (a) (b)

(c) 782 784 868 434 641 11 77 88 44 88 793 861 956 478 729 1,000,000 2 2 2 2 2 23. (3,622) (3,706) (493) (1,053) (1,039) (176) (83) (99) (57) (46) (3,798) (3,789) (592) (1,110) (1,085) 1,271 4,259 6,236 1,287 4,157 (2,527) 470 5,644 177 3,072

24. (a) (b) (c) 15% 33% 7.5% 25% 18% 20% 22% 25% 15%

17,133 49,032 114,516 34,246 44,710 19 (30) 4,589 (47,146) 2,089 (2,027) 17,103 53,621 67,370 36,335 42,683 (a) (11,477) 5,626 53,621 67,370 36,335 42,683 (a) 50% 15% 7.5% 15%

184,452 287,069 381,026 147,171 290,095 31,020 80,390 115,697 24,367 59,159 (2,607) (589) (589) 3,196 3,196 (663) (888) (653) (291) (451) 6,745 13,285 13,285 2,000 (14,236) (33,414) (72,081) (10,479) (23,434) 429 550 934 1,516 649 553 2,845 7,581 5,330 4,760 17,103 53,621 67,370 36,335 42,683 19,112 14,693 37,643 37,643 98,869 29 1,075 (11,150) (26,082) (53,290) (26,801) (57,916) 17,133 49,032 114,516 34,246 44,710 (11,477) 14,693 37,643 98,869 45,088 85,663

25. (a) 179,266 237,059 326,316 119,594 254,849 448,918 470,000 470,000 470,000 470,000 39.93 50.44 69.43 25.45 54.22 (b) 26. 15.3 15.3 71,558 71,558 13.0 10.2 60,656 48,471 60,656 120,029 71,558

27. 184,452 287,069 381,026 147,171 290,095 6 5,362 8,330 11,694 6,672 7,449 7 8,648 17,118 15,726 8,565 8,709 7 930 22,805 80,261 80,261 8 382 942 1,129 564 564 30 98 50 7 1,535 238 29(b) 264 20 (38,201) (38,201) 20 (13,252) 23 (1,271) (4,259) (6,236) (1,287) (4,157) 9 (10,427) (2,357) (2,357) 185,515 323,143 443,378 201,388 302,710 (9,535) (16,442) (3,572) (11,208) (6,331) (1,427) (40,077) (37,708) (3,605) (27,331) 19,162 16,277 36,840 11,560 (27,148) 193,715 282,901 438,938 198,135 241,900

6 302 30 234 50 (30) (98) (50) 302 136 28. (a) 32,500 35,715 2,739 10,409 59,662 31,034 23,089 29,332 127,877 31,034 25,828 39,741

(b) 991 2,573 659 807 271 1,604 138 826 506 213 1,129 3,399 1,436 2,624

29. (a) (i) 60,000,000 11,695 11,695 5,067 5,067 6,238 6,238 508 508 33,000 16,114 28,000 84,508 39,622 (25,678) (25,678) (9,561) (1,105) (1,105) (36,344) (26,783) 48,164 12,839 48,164 11,836 60,000 (11,695) 48,305 36,305 6,000 6,000 48,305

26,384,000 4,639,000 350,990,000 187,373,000 (ii) 3,758,000 1,861 1,861 37 37 1,898 1,898 1,898 1,898 1,898 1,860 3,758 (1,861) 1,897 78,620,000 20,688,000 510,048,000 233,448,000

(iii) 62,500,000 60% 564 564 596 596 17,520 7,288 10,600 4,057 31,000 50,015 60,280 62,520 10,448 10,448 4,194 14,642 10,448 45,638 52,072 60% 27,383 35,117 62,500 (564) (30,000) 31,936 1,280,000 7,768,000 512,548,000 235,073,000

(iv) 4,000,000 60% 4,019 4,019 117 117 10 10 4,146 4,146 (1,018) (1,018) (1,018) (1,018) 3,128 3,128 60% 2,057 1,943 4,000 (4,019) (19) 19,000 473,437,000246,913,000

(b) 49% 49 134 3,348 1,372 4,903 (370) (370) 4,533 49% 2,221 (2,485) (264) 30. 13 17 22

III. 173,939,030 China Pharma 173,939,030 China Pharma

IV. III UBS AG [ ]

A. B. C.

1 4 5 6 7 2 3

512

B.Sc. FRICS FHKIS [ ] 27 30

1. 2,996,000 100% 2,996,000 48 25 2501 2505 2 2. 32,119,000 100% 32,119,000 3. 20,802,000 60% 12,481,000 2518 4. 18,779,000 100% 18,779,000 88 25 25B 25C 25D

5. 2,161,000 100% 2,161,000 3699 14 1414 1415 76,857,000 68,536,000 6. 3,794,000 100% 3,794,000 97 2000 14 1707 7. 5,526,000 100% 5,526,000 48 31 3105 3108 9,320,000 9,320,000

8. 3,989,000 51% 2,034,000 3,989,000 2,034,000 9. 85 26 27 6 10. 99 2000 18 2101 2103 2105 2108

11. 3 12. A06-2 2 6 13. 1587 5 14. 36 8 2 203 15.

16. 5 A 3 1 B 3 4 17. 33 A 3 18. 9 8 4 9 7 19. 9 11 3 20.

21. 7 11 26 90,166,000 79,890,000

1. 2,996,000 31 25 2 2 100% 48 2,996,000 25 2501 502.94 2505 2 1. 4 200603019 200603023 200602671 200602672 81.06 2. 4HK060410 HK060413 HK066214 HK066220 502.94 22 3. a.

2. 32,119,000 25,328.55 8 15,304.85 100% 32,119,000 3 1 1 3 1. 25,328.6 1,773,002 2. (2006 ) 04225,328.55 3. 0611800 10,444.95 3 4. 54,859.9 5. 521 260.5 15 6. 4 55 5,120.4 4,604,000

7. a. b. 3 c. 42 1,407.4 d. 4 3,452.53

3. 20,802,000 2518 13,348 4 7,719.57 1 1 2 60% 12,481,000 1. 60% (2002) 1913,348 1,022,456.8 2. (2005) 0100059 13,348 3. 2 011524 011525 7,574.93 2 4. 2 144.64 5. 4 2 144.64 65,000

6. a. b. 3 c. 4

4. 18,779,000 54 25 3 100% 88 25 18,779,000 25B 25C 553.94 25D 1. 3553.94 3 15,510,320 2. 33000530734 3000530735 3000530440 553.94 3 3.

5. 2,161,000 18 14 2 100% 3699 2,161,000 14 1414 1415 120.75 1. 2120.75 2 2,135,464 2. 2 (2010) 011241 011242 2 120.75 3.

6. 3,794,000 97 2000 24 14 200.73 100% 3,794,000 14 1707 1. (2004 ) 0029 3,885.34 2. 200.73 2,470,456 3. X 612012 200.73 4. 2000 14 1200.73 21,800 5. a. b.

7. 5,526,000 31 31 4 100% 48 5,526,000 31 739.74 3105 3108 1. 4 200603070 200603073 119.23 2. 4HK042100 HK042101 HK042103 HK042104 739.74 4 3. 31 4 740 42,180 4. a. b.

8. 3,989,000 33,333 6 4 9,240.6 51% 2,034,000 300,000 1 32 3,350.38 20 19,044,000 1. 51% C13102320090021 33,333 4,380,000

2. (2009) 193 33,333 3. 131023X100010101 4. 17,100,000 5. a. b. c.

9. 45 26 27 6 85 26 27 6 2,737.12 1. 121 2,737.12 23,813,104 2. 38,776,000 3. 4.

10. 24 18 7 2107 2105 2106 99 2000 1,695.8 18 2101 2103 2105 2108 1. 71,695.8 7 27,980,000 2. 2107 2105 2106 2 371.06 39,502.43 3. 33,479,000 4. 5.

11. 3 106 3 2,400 1. 2,400 2. a. b.

12. A06-2 2 6 1,196 A 2 6 B B 386 A A B 36,364 1. A A B 36,364 2. A 1,195 3. 2 1,052,000

4. a. b. B c. 2 3 d. 22 3 2 3 e. B

13. 114 6 5 1587 5 441.52 60% 8,350 1. 5 8,350 2. a. 394.52 4 b. 2a4 c. d.

14. 242 36 80 8 2 203 60% 1,100 1. 1,100 2. a. b.

15. 2,178 150,000 1. 150,000 2. 260.5 521 2 3. a. b. 2

16. 5 3 5 5 435 A 3 1 B 3 4 460,776 1. 2 460,776 2. a. b. c.

17. 53 33 608 A 3 221,920 1. 1 221,920 2. a. b.

18. 6 4 7 7 1,400 9 8 4 9 7 252,000 1. 252,000 2. a. b.

19. 7 3 400 9 11 3 72,000 1. 72,000 2. a. b.

20. 30 20,000.1 51% 1,000 1. 1,000 2. 132 3,350.38 8300,000 3. a. 2 b.

21. 19 11 7 11 26 114 14,952 1. 14,952 2. 60% 3. a. b. c.

1. 42A 2. (a) (i)

(ii) (iii) (iv) (v)

(vi) (aa) (bb)

(cc) (dd) (ee) 5% (ff) (vii)

(viii) (14)

(ix) (b) (c) (i) (ii)

(iii) (iv) (v) (vi) (vii) (d) (e) 21 (10)

95%) (21) (10) (f) (g) 15

(h) (21)

(i) (21) (20) (e) (21) (10) (14) (10) (j)

(30) (k) (l) (m) (i) (ii) (a) (b)

(n) (o) (20%) (14)

(20%) (p) (q) (r) 4(e) (s)

(t) (i)312 (ii) 12 (iii) 3 (u) 3. (21)

95% (21) 4. (a) (i) (ii) (aa) (bb) (iii)

(b) (c) (i)(ii) (iii) (i) (ii)

42A (d) (i) (ii) 54 (e)

(f) (g) (i) (ii) (iii) (5)

(21) (7) (h) (21) (7) (15) (i)

(j) (k) (l) (20%)(a) (b) (c) 98(2)(c)

(m) (2) (14) (2) 87A (n)

1 5. Conyers Dill & Pearman

10%

10% 10%

25% 15% 7.5% 9% 10% 11% 15% 15% 25% 15% 17% 17%

5% 16.5%15.0% 0.1% 0.2% 5

;

G B1 B2 C E A

GMP GMPGMP GMP

GMP GMP GMP GMP GMP GMP GMP GMPGMP GMP

30 49% GSP GSPGSP GSP GSP 2004 GSP

115% 125%

896 927

15% 10 101.5 101.5 203

10 1.5 203 101.5 50.7 70%

[ ] 30

2009

A. 1. 15 8 XI 15 8 2. [ ] [ ] [ ] (1) [ ] [ ] [ ] [ ] (2) [ ] [ ] [ ] [ ] [ ] [ ] (3) (i) [ ] [ ] [ ] (ii) [ ] (iii) [ ] (iv) [ ]

[ ] [ ] [ ] 3. (a) (b) 9,400,000,000 6,000,000 100,000,000 (c) (d) [ ] [ ] (e) [ ] 20% (f) [ ]20%

4. [ ] China Pharma 5. 500,000 1,000,000 700,000 300,000 6. [ ] (e) [ ] (f) [ ] (g) [ ] [ ] [ ]

[ ] B. 1. (a) China Pharma10,000 (b) 38,872,000 17.2% (c) 62,828,000 27.8% (d) 1.148 560,000 41% 20% (e) (f) China Pharma 10,000 China Pharma (g) MSPEA Pharma BV China Pharma

(h) (i) (j) (k) (l) China Pharma MSPEA Pharma BV MSPEA Pharma BV Top Matrix (m) Plenty Gold (n) (o) (p) (q) (r) (s) (t) (u) (v) Plenty Gold [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ]

2. (a) 2006-8-22 2026-08-22 ZL 2006 1 594531 A 0125935.8 2006-8-22 2026-08-22 ZL 2006 1 559377 0125936.2 2006-9-13 2026-09-13 ZL 2006 1 608371 0153342.2 2006-9-13 2026-09-13 ZL 2006 1 606712 0153341.8 2006-12-4 2026-12-04 ZL 2006 1 536548 0163472.4 2006-3-24 2026-03-24 ZL 2006 1 574341 0043263.6 2006-3-24 2026-03-24 ZL 2006 1 574342 IIA 0043264.0

2006-7-7 2026-07-07 ZL 2006 1 544411 0045298.3 2006-7-14 2026-07-14 ZL 2006 1 619597 0045491.7 2006-8-17 2026-08-17 ZL 2006 1 609369 0108878.2 2006-10-9 2026-10-9 ZL 2006 1 492324 0135841.9 2006-10-25 2026-10-25 ZL 2006 1 492335 0142637.X 2006-10-25 2026-10-25 ZL 2006 1 594570 0142636.5 2006-10-25 2026-10-25 ZL 2006 1 559450 0142635.0 2007-2-1 2027-2-1 200710006870.X 673395 2008-8-6 2028-8-6 200810145497.0 673522

2006-11-22 2026-11-22 200610149 673337 186.0 2005-11-10 2025-11-10 ZL 2005 1 620465 0045068.2 2006-12-29 2026-12-29 ZL 2006 1 620590 0172624.7 2006-1-24 2026-01-24 ZL 2006 1 584983 0042221.0 2006-3-24 2026-03-24 ZL 2006 1 544401 0043265.5 2005-10-26 2025-10-26 ZL 2005 1 620366 0104354.1 2006-5-30 2026-05-30 ZL 2006 1 504176 0082107.0 2006-11-21 2026-11-21 ZL 2006 1 585293 0149188.1 2006-12-4 2026-12-06 ZL 2006 1 623970 0163453.1 2006-12-4 2026-12-04 ZL 2006 1 621131 0163475.8 2006-12-6 2026-12-06 ZL 2006 1 620588 0163454.6

2005-12-19 2025-12-19 ZL 2005 1 620236 0045376.5 2005-12-19 2025-12-19 ZL 2005 1 620355 0045378.4 2006-4-7 2026-04-07 ZL 2006 1 594347 0043505.1 2006-4-29 2026-04-29 ZL 2006 1 594349 0043897.1 2005-9-13 2025-09-13 ZL 2005 1 349435 044573.5 2005-12-26 2025-12-26 ZL 2005 1 573849 0131121.0 2006-2-27 2026-02-27 ZL 2006 1 559029 0042439.6 2006-4-24 2026-04-24 ZL 2006 1 559034 0043851.X 2006-8-4 2026-08-04 ZL 2006 1 559130 0069657.9 2006-8-18 2026-08-18 ZL 2006 1 574414 0068402.0

2005-12-23 2025-12-23 ZL 2005 1 350428 0131154.5 3-2006-11-8 2026-11-08 ZL 2006 1 622192 0147177.X 2008-02-03 2028-02-03 ZL 2008 1 631135 0074350.7 2007-12-1 2027-12-1 ZL 2007 1 629202 0197037.8 2,5-2006-10-12 2026-10-12 ZL 2006 1 544766 0131958.X 2005-9-6 2025-09-05 ZL 2005 1 481261 0044552.3 B 2006-2-17 2028-06-11 ZL 2006 1 403466 0007834.0 2004-11-22 2024-11-22 ZL 2004 1 254702 0009826.0 2006-7-21 2026-7-21 ZL 2006 1 582459 0103455.1 2008-4-24 2028-4-24 ZL 2008 1 560419 0093966.9